ALISSA DELANO: Open Payments
NPI 1437702826 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 37 payments from 11 companies in 2025. Trend: 2023 $366 · 2024 $331 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $164 |
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| Novo Nordisk Inc | 3 | $60 |
| Corcept Therapeutics | 3 | $53 |
| Astellas Pharma US Inc | 1 | $33 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 3 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: AIRSUPRA, VRAYLAR, UBRELVY, Korlym, Wegovy, Veozah, Auvelity, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
